Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20202082 | 0.84 | MAPK1 (0.53) | MAPK1L3MBTL1GAAKMT2AKDM4E | |
| SCHEMBL26771372 | 0.83 | L3MBTL1 (0.50) | MAPK1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL20202081 | 0.82 | KMT2A (0.42) | L3MBTL1GAAKMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL13202711 | 0.82 | GAA (0.51) | MAPK1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL14803911 | 0.79 | L3MBTL1 (0.51) | MAPK1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL20202079 | 0.79 | APP (0.55) | L3MBTL1GAAKMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL24703646 | 0.76 | PPARA (0.40) | MAPK1L3MBTL1KDM4EMAPTHTT | |
| SCHEMBL9342407 | 0.76 | MAPK1 (0.60) | MAPK1L3MBTL1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL26832126 | 0.75 | L3MBTL1 (0.50) | MAPK1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL16998556 | 0.74 | MAPK1 (0.53) | MAPK1L3MBTL1KMT2AKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | BIOME BIOPLASTICS LIMITED (GB) | 2023-11-07 | — | — | US | disclosed |
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | BIOME BIOPLASTICS LIMITED (GB) | 2023-11-07 | — | — | US | disclosed |
| US-20180148752-A1 | PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM | BIOME BIOPLASTICS LIMITED (GB) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | HPD, PGD, PCCA | MAPK1 3440/4885L3MBTL1 4557/4885GAA 1252/4885 |
| US-20180148752-A1 | PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM | HPD, PCCA, MVD | MAPK1 2904/4885L3MBTL1 4344/4885GAA 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.